EP1140120A4 - Human brainiac-5 - Google Patents

Human brainiac-5

Info

Publication number
EP1140120A4
EP1140120A4 EP99966502A EP99966502A EP1140120A4 EP 1140120 A4 EP1140120 A4 EP 1140120A4 EP 99966502 A EP99966502 A EP 99966502A EP 99966502 A EP99966502 A EP 99966502A EP 1140120 A4 EP1140120 A4 EP 1140120A4
Authority
EP
European Patent Office
Prior art keywords
brainiac
human
human brainiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99966502A
Other languages
German (de)
French (fr)
Other versions
EP1140120A2 (en
Inventor
Paul E Young
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1140120A2 publication Critical patent/EP1140120A2/en
Publication of EP1140120A4 publication Critical patent/EP1140120A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99966502A 1998-12-23 1999-12-20 Human brainiac-5 Withdrawn EP1140120A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11380498P 1998-12-23 1998-12-23
US113804P 1998-12-23
PCT/US1999/030452 WO2000039136A2 (en) 1998-12-23 1999-12-20 Human brainiac-5

Publications (2)

Publication Number Publication Date
EP1140120A2 EP1140120A2 (en) 2001-10-10
EP1140120A4 true EP1140120A4 (en) 2003-05-07

Family

ID=22351630

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99966502A Withdrawn EP1140120A4 (en) 1998-12-23 1999-12-20 Human brainiac-5

Country Status (5)

Country Link
EP (1) EP1140120A4 (en)
JP (1) JP2002533109A (en)
AU (1) AU2202100A (en)
CA (1) CA2356548A1 (en)
WO (1) WO2000039136A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
WO2011082345A2 (en) 2009-12-30 2011-07-07 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
CN114933646A (en) * 2022-06-22 2022-08-23 南通市第一老年病医院(上海大学附属南通医院、南通市第六人民医院、南通市肺科医院) SMAGP protein polypeptide construction and application of SMAGP protein polypeptide in anti-fatty liver disease activity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044112A1 (en) * 1997-03-28 1998-10-08 Human Genome Sciences, Inc. Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
WO1999031116A1 (en) * 1997-12-18 1999-06-24 Human Genome Sciences, Inc. Human dendriac and brainiac-3
WO2000053750A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941320A2 (en) * 1996-11-13 1999-09-15 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044112A1 (en) * 1997-03-28 1998-10-08 Human Genome Sciences, Inc. Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
WO1999031116A1 (en) * 1997-12-18 1999-06-24 Human Genome Sciences, Inc. Human dendriac and brainiac-3
WO2000053750A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of tumors

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 14 January 1998 (1998-01-14), "UDP-galactose-2-acetamido-2-deoxy-D-glucose-3-beta-galactosyltransferase", XP002228624, retrieved from CNBI Database accession no. Y15014 *
DATABASE EMBL [online] 18 January 1999 (1999-01-18), "Human cardiac and pancreatic protein (CAPP)", XP002228625, retrieved from EBI Database accession no. AAW80212 *
DATABASE EMBL [online] 25 January 2001 (2001-01-25), "Human PRO4397 nucleotide sequence SEQ ID NŸ41", XP002234112, retrieved from EBI Database accession no. AAC58117 *
DATABASE EMBL [online] 25 January 2001 (2001-01-25), "Human PRO4397 protein sequence SEQ ID NŸ42;", XP002228628, retrieved from EBI Database accession no. AAB24035 *
DATABASE EMBL [online] 27 September 1999 (1999-09-27), "Human brainiac-3 cDNA", XP002234111, retrieved from EBI Database accession no. AAX87194 *
DATABASE EMBL [online] 27 September 1999 (1999-09-27), "Human brainiac-3", XP002228627, retrieved from EBI Database accession no. AAY06462 *
DATABASE EMBL [online] 4 August 1999 (1999-08-04), "Homo sapiens chromosome 16 clone CTA-277H1, working draft sequence", XP002228626, retrieved from EBI Database accession no. AC008594 *
DATABASE EMBL [online] 9 January 1996 (1996-01-09), "Drosophila megalogaster putative neurogenic secreted signaling protein (brn) mRNA, complete cds.", XP002228623, retrieved from NCBI Database accession no. U41449 *
GOODE S ET AL: "BRAINIAC AND FRINGE ARE SIMILAR PIONEER PROTEINS THAT IMPART SPECIFICITY TO NOTCH SIGNALING DURING DROSOPHILA DEVELOPMENT", COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, NEW YORK, NY, US, vol. 62, 1997, pages 177 - 184, XP001041794 *
See also references of WO0039136A3 *

Also Published As

Publication number Publication date
AU2202100A (en) 2000-07-31
JP2002533109A (en) 2002-10-08
WO2000039136A2 (en) 2000-07-06
EP1140120A2 (en) 2001-10-10
WO2000039136A3 (en) 2000-11-02
CA2356548A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
GB9807302D0 (en) Endoscope
PL328822A1 (en) Human bikinine
GB9804885D0 (en) Therapeutic combination
GB9818914D0 (en) Use
EP1077996A4 (en) HUMAN EDG3sb GENE
AU142196S (en) Tissue
GB9802599D0 (en) Medical use
GB2339924B (en) Endoscope
GB9816556D0 (en) Therapy
AU142195S (en) Tissue
AU140956S (en) Tissue
EP1194439A4 (en) Human eag2
AU2227999A (en) Human ependymin
EP1140120A4 (en) Human brainiac-5
EP1077258A4 (en) Human hrpi
GB9807503D0 (en) Use
GB9828004D0 (en) Use
GB9810920D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
AU142197S (en) Tissue
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010704

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/705 B

Ipc: 7C 12N 15/85 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12N 15/11 B

Ipc: 7C 12N 5/14 B

Ipc: 7C 12N 1/19 B

Ipc: 7C 12N 1/15 B

Ipc: 7C 12N 1/21 B

Ipc: 7C 07H 21/04 B

Ipc: 7C 07H 21/02 B

Ipc: 7A 61K 35/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030325

17Q First examination report despatched

Effective date: 20031117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050615